Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infectious and immunological sequelae of daratumumab in multiple myeloma.

× No keyword cloud information.

6 in total

1. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.

Authors: Vaishali Sanchorawala; Shayna Sarosiek; Amanda Schulman; Meredith Mistark; Mary Ellen Migre; Ramon Cruz; J Mark Sloan; Dina Brauneis; Anthony C Shelton
Journal: Blood Date: 2020-04-30 Impact factor: 22.113

2. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes.

Authors: M J Steinhardt; E Wiercinska; M Pham; G U Grigoleit; A Mazzoni; M Da-Via; X Zhou; K Meckel; K Nickel; J Duell; F C Krummenast; S Kraus; C Hopkinson; B Weissbrich; W Müllges; G Stoll; K M Kortüm; H Einsele; H Bonig; L Rasche
Journal: J Transl Med Date: 2020-04-21 Impact factor: 5.531

Infectious and immunological sequelae of daratumumab in multiple myeloma.

1. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.

2. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes.

3. [Progress in the treatment of multiple myeloma with daratumumab].

4. Case Report: Invasive Fungal Infection and Daratumumab: A Case Series and Review of Literature.

Review 5. Infections associated with the new 'nibs and mabs' and cellular therapies.

6. COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination.